Risk prediction and end-points in idiopathic pulmonary fibrosis: one step at a time
نویسندگان
چکیده
منابع مشابه
Risk prediction and end-points in idiopathic pulmonary fibrosis: one step at a time.
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with a median survival of approximately 3 years from diagnosis. Accurate prediction of mortality is important in IPF, as it helps determine the urgency of lung transplantation, guides other management and end-of-life decisions, and facilitates enrichment of clinical trial populations. Although most patients with IPF die f...
متن کاملA first step against idiopathic pulmonary fibrosis.
I diopathic pulmonary fibrosis (IPF) is a chronic devastating disease affecting 50 to 300 individuals per million with a median survival time of ,3 yrs [1]. The recent publication of evidence-based guidelines for the diagnosis and management of patients with IPF did not provide patients and care givers with any reason for optimism [2]. The only recommended procedures in this document were: long...
متن کاملPulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Chance for a Multidisciplinary Treatment Approach
Background and Objectives: Idiopathic pulmonary fibrosis (IPF) is characterized by progressively worsening lung function, ventilation capacity, dyspnea, and finally reduced exercise intolerance. All of these have a significant negative impact on functional capacity and quality of life. In this study, we aim to evaluate the effects of pulmonary rehabilitation (PR) in IPF and assess the predictor...
متن کاملPediatric Idiopathic Pulmonary Fibrosis: A Case Series report
Khalilzadeh S1, Baghaei N2, Bolorsaz MR1, Masjedi MR3 1. Associate professor, Department of pediatrics, Education, research and treatment center of tuberculosis and long diseases, Shahid Beheshti University of medical sciences 2. Assistant professor, Department of pediatrics, Education, research and treatment center of tuberculosis and long diseases, Shahid Beheshti University of medical s...
متن کاملChallenges in idiopathic pulmonary fibrosis trials: the point on end-points.
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias and is associated with both a variable clinical course and a poor prognosis. Investigators involved in clinical trials and clinicians reviewing the IPF literature are confronted with daunting challenges in selecting reliable outcome measures, interpreting the clinical and statistical importance of t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Respiratory Journal
سال: 2014
ISSN: 0903-1936,1399-3003
DOI: 10.1183/09031936.00021814